Ji-Yong Qin
Overview
Explore the profile of Ji-Yong Qin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tang L, Chen Y, Chen C, Chen M, Chen N, Chen X, et al.
Cancer Commun (Lond)
. 2021 Oct;
41(11):1195-1227.
PMID: 34699681
Nasopharyngeal carcinoma (NPC) is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa. To develop these comprehensive guidelines for the...
2.
Xiong W, Liao Y, Qin J, Li W, Tang Z
Genes Dis
. 2020 Sep;
7(3):351-358.
PMID: 32884989
The phenomenon of enhanced invasion and metastasis of residual tumor cells has been observed in an increasing number of patients receiving chemoradiotherapy recently, and tumor metastasis will undoubtedly limit patient...
3.
Xiong W, Ai Y, Li Y, Ye Q, Chen Z, Qin J, et al.
Biomed Res Int
. 2017 Jun;
2017:8421614.
PMID: 28656150
Preoperative 5-fluorouracil- (5-FU-) based chemoradiotherapy is a standard treatment for locally advanced colorectal cancer (CRC). However, the effect of 5-FU-based chemoradiotherapy on CRC is limited due to the development of...
4.
Xiong W, Jiang Y, Ai Y, Liu S, Wu X, Cui J, et al.
Asian Pac J Cancer Prev
. 2015 Apr;
16(8):3395-402.
PMID: 25921151
Background: Preoperative 5-fluorouracil (5-FU)-based chemoradiotherapy is a standard treatment for locally advanced colorectal cancer (CRC). However, CRC cells often develop chemoradiation resistance (CRR). Recent studies have shown that long non-coding...